Staff Publications: June 2017

  1. Adelstein D, Gillison ML, Pfister DG, et al. Nccn Guidelines Insights: Head and Neck Cancers, Version 2.2017. J Natl Compr Canc Netw. 2017;15(6):761-770. PMID: 28596256.
  2. Al-Ashmawy AAK, Ragab FA, Elokely KM, et al. Design, Synthesis and Sar of New-Di-Substituted Pyridopyrimidines as Atp-Competitive Dual Pi3kalpha/Mtor Inhibitors. Bioorg Med Chem Lett. 2017;27(14):3117-3122. PMID: 28571824.
  3. Alexander J, Cukierman E. Stromal Dynamic Reciprocity in Cancer: Intricacies of Fibroblastic-Ecm Interactions. Curr Opin Cell Biol. 2016;42:80-93. PMID: 27214794. PMC5064819. NIHMS786085.
  4. Alford RF, Leaver-Fay A, Jeliazkov JR, et al. The Rosetta All-Atom Energy Function for Macromolecular Modeling and Design. Journal of Chemical Theory and Computation. 2017;13(6):3031-3048.
  5. Ali N, Kutikov A, Geynisman DM. Resolution of a Debilitating Paraneoplastic Parkinson-Like Neurological Syndrome Following Tyrosine Inhibitor Therapy and Consolidative Nephrectomy in a Patient with Advanced Clear Cell Renal Cell Carcinoma. Urol Case Rep. 2017;14:18-20. PMID: 28660133. PMC5479944.
  6. Al-Khalifa SE, Jennings MC, Wuest WM, Minbiole KP. The Development of Next-Generation Pyridinium-Based Multiqac Antiseptics. ChemMedChem. 2017;12(4):280-283. PMID: 28033453.
  7. Blaauwgeers H, Flieder D, Warth A, et al. A Prospective Study of Loose Tissue Fragments in Non-Small Cell Lung Cancer Resection Specimens: An Alternative View to “Spread through Air Spaces”. Am J Surg Pathol. 2017. PMID: 28622180.
  8. Borgmann H, Katz MS, Catto J, Weight C, Kutikov A. Quantification of Urology Related Twitter Traffic Activity through a Standardized List of Social Media Communication Descriptors. Urology Practice. 2017;4(4):349-354.
  9. Carbone DP, Reck M, Paz-Ares L, et al. First-Line Nivolumab in Stage Iv or Recurrent Non-Small-Cell Lung Cancer. N Engl J Med. 2017;376(25):2415-2426. PMID: 28636851.
  10. Choueiri TK, Plimack E, Arkenau HT, et al. Biomarker-Based Phase Ii Trial of Savolitinib in Patients with Advanced Papillary Renal Cell Cancer. J Clin Oncol. 2017:Jco2017722967. PMID: 28644771.
  11. De Bari B, Stish B, Ball MW, et al. Adult Prostatic Sarcoma: A Contemporary Multicenter Rare Cancer Network Study. Prostate. 2017;77(10):1160-1166. PMID: 28594087.
  12. Deihimi S, Lev A, Slifker M, et al. Brca2, Egfr, and Ntrk Mutations in Mismatch Repair-Deficient Colorectal Cancers with Msh2 or Mlh1 Mutations. Oncotarget. 2017;8(25):39945-39962. PMID: 28591715.
  13. Edelman MJ, Hu C, Le QT, et al. Randomized Phase Ii Study of Preoperative Chemoradiotherapy +/- Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage Iiia, N2+) Non-Small Cell Lung Cancer: Nrg Oncology Rtog 0839. J Thorac Oncol. 2017. PMID: 28629896.
  14. Erkmen CP, Mitchell M, Randhawa S, et al. An Enhanced Shared Decision Making Model to Address Willingness and Ability to Undergo Lung Cancer Screening and Follow-up Treatment in Minority Underserved Populations. J Community Health. 2017. PMID: 28612174.
  15. Faries MB, Thompson JF, Cochran AJ, et al. Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. N Engl J Med. 2017;376(23):2211-2222. PMID: 28591523.
  16. Gallego-Villar L, Hannibal L, Haberle J, et al. Cysteamine Revisited: Repair of Arginine to Cysteine Mutations. J Inherit Metab Dis. 2017. PMID: 28643139.
  17. Ge Y, Kier BL, Andersen NH, Voelz VA. Computational and Experimental Evaluation of Designed Beta-Cap Hairpins Using Molecular Simulations and Kinetic Network Models. J Chem Inf Model. 2017. PMID: 28614661.
  18. Gokare P, El-Deiry WS. The Tuberous Sclerosis Complex Gets Fatter. Oncotarget. 2017;8(26):41780-41781. PMID: 28611315.
  19. Goldstein LJ, Zhao F, Wang M, et al. A Phase I/Ii Study of Suberoylanilide Hydroxamic Acid (SAHA) in Combination with Trastuzumab (Herceptin) in Patients with Advanced Metastatic and/or Local Chest Wall Recurrent Her2-Amplified Breast Cancer: A Trial of the Ecog-Acrin Cancer Research Group (E1104). Breast Cancer Res Treat. 2017. PMID: 28623430.
  20. Hahn NM, Bivalacqua TJ, Ross AE, et al. A Phase Ii Trial of Dovitinib in Bcg-Unresponsive Urothelial Carcinoma with Fgfr3 Mutations or Overexpression: Hoosier Cancer Research Network Trial Hcrn 12-157. Clinical Cancer Research. 2017;23(12):3003-3011.
  21. Hensley ML, Patel SR, von Mehren M, et al. Efficacy and Safety of Trabectedin or Dacarbazine in Patients with Advanced Uterine Leiomyosarcoma after Failure of Anthracycline-Based Chemotherapy: Subgroup Analysis of a Phase 3, Randomized Clinical Trial. Gynecol Oncol. 2017. PMID: 28651804.
  22. Herts BR, Silverman SG, Hindman NM, et al. Management of the Incidental Renal Mass on Ct: A White Paper of the Acr Incidental Findings Committee. J Am Coll Radiol. 2017. PMID: 28651987.
  23. Hou P, Wu C, Wang Y, et al. A Genome-Wide Crispr Screen Identifies Genes Critical for Resistance to Flt3 Inhibitor Ac220. Cancer Res. 2017. PMID: 28625976.
  24. Hurwitz MD, Harris J, Sartor O, et al. Adjuvant Radiation Therapy, Androgen Deprivation, and Docetaxel for High-Risk Prostate Cancer Postprostatectomy: Results of Nrg Oncology/Rtog Study 0621. Cancer. 2017;123(13):2489-2496.
  25. Jaffe EK. New Protein Structures Provide an Updated Understanding of Phenylketonuria. Mol Genet Metab. 2017. PMID: 28645531.
  26. Jamal N, Ebersole B, Erman A, Chhetri D. Maximizing Functional Outcomes in Head and Neck Cancer Survivors: Assessment and Rehabilitation. Otolaryngol Clin North Am. 2017. PMID: 28606600.
  27. Jiang W, Dulaimi E, Devarajan K, et al. Intratumoral Heterogeneity Analysis Reveals Hidden Associations between Protein Expression Losses and Patient Survival in Clear Cell Renal Cell Carcinoma. Oncotarget. 2017;8(23):37423-37434.
  28. Judd J, Zibelman M, Handorf E, et al. Immune-Related Adverse Events as a Biomarker in Non-Melanoma Patients Treated with Programmed Cell Death 1 Inhibitors. Oncologist. 2017. PMID: 28652280.
  29. Kim SP, Campbell SC, Gill I, et al. Collaborative Review of Risk Benefit Trade-Offs between Partial and Radical Nephrectomy in the Management of Anatomically Complex Renal Masses. Eur Urol. 2017;72(1):64-75.
  30. Kruger WD. Cystathionine Beta-Synthase Deficiency: Of Mice and Men. Mol Genet Metab. 2017;121(3):199-205. PMID: 28583326.
  31. Kuchenbaecker KB, Hopper JL, Barnes DR, et al. Risks of Breast, Ovarian, and Contralateral Breast Cancer for Brca1 and Brca2 Mutation Carriers. Jama. 2017;317(23):2402-2416. PMID: 28632866.
  32. Kuchenbaecker KB, McGuffog L, Barrowdale D, et al. Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in Brca1 and Brca2 Mutation Carriers. J Natl Cancer Inst. 2017;109(7). PMID: 28376175. PMC5408990.
  33. Liu T, Kan XF, Ma C, et al. Gpx2 Overexpression Indicates Poor Prognosis in Patients with Hepatocellular Carcinoma. Tumour Biol. 2017;39(6):1010428317700410. PMID: 28635398.
  34. Lu W, Liu Y, Ma H, et al. Design, Synthesis, and Structure-Activity Relationship of Tetrahydropyrido[4,3-D]Pyrimidine Derivatives as Potent Smoothened Antagonists with in Vivo Activity. ACS Chem Neurosci. 2017. PMID: 28618224.
  35. Menzel LP, Chowdhury HM, Masso-Silva JA, et al. Potent in Vitro and in Vivo Antifungal Activity of a Small Molecule Host Defense Peptide Mimic through a Membrane-Active Mechanism. Sci Rep. 2017;7(1):4353. PMID: 28659617.
  36. Mortazavi SMJ, Mortazavi G, Paknahad M. Phase Down of Amalgam. Awareness of Minamata Convention among Jordanian Dentists. Saudi Medical Journal. 2017;38(5):560.
  37. Mortazavi SMJ, Mortazavi SAR. Auricular Hematoma Cases Caused by Mobile Phones. Oral and Maxillofacial Surgery Cases. 2017;3(3):54-55.
  38. Motzer RJ, Jonasch E, Agarwal N, et al. Kidney Cancer, Version 2.2017: Clinical Practice Guidelines in Oncology. JNCCN Journal of the National Comprehensive Cancer Network. 2017;15(6):804-834.
  39. Necchi A, Mariani L, Lo Vullo S, et al. Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes Only: A Propensity Score-Based Analysis. European Urology Focus. 2017.
  40. Pal SK, Ali SM, Yakirevich E, et al. Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma Via Comprehensive Genomic Profiling. Eur Urol. 2017. PMID: 28592388.
  41. Papadopoulos KP, Gluck L, Martin LP, et al. First-in-Human Study of Amg 820, a Monoclonal Anti-Colony-Stimulating Factor 1 Receptor Antibody, in Patients with Advanced Solid Tumors. Clin Cancer Res. 2017. PMID: 28655795.
  42. Prinsep MR, Appleton TG, Hanson GR, et al. Tolyporphin Macrocycles from the Cyanobacterium Tolypothrix Nodosa Selectively Bind Copper and Silver and Reverse Multidrug Resistance. Inorganic Chemistry. 2017;56(10):5577-5585.
  43. \Razavi AM, Delemotte L, Berlin JR, Carnevale V, Voelz VA. Molecular Simulations and Free-Energy Calculations Suggest Conformation-Dependent Anion Binding to a Cytoplasmic Site as a Mechanism for Na+/K+-Atpase Ion Selectivity. J Biol Chem. 2017. PMID: 28588025.
  44. Terry MB, Keegan THM, Houghton LC, et al. Pubertal Development in Girls by Breast Cancer Family History: The Legacy Girls Cohort. Breast Cancer Res. 2017;19(1):69. PMID: 28595647. PMC5465536.
  45. van Tuyn J, Jaber-Hijazi F, MacKenzie D, et al. Oncogene-Expressing Senescent Melanocytes Upregulate Mhc Class Ii, a Candidate Melanoma Suppressor Function. J Invest Dermatol. 2017. PMID: 28647344.
  46. Wang HH, Deng L, Wen QL, et al. Early Postoperative Radiotherapy Is Associated with Improved Outcomes over Late Postoperative Radiotherapy in the Management of Completely Resected (R0) Stage Iiia-N2 Non-Small Cell Lung Cancer. Oncotarget. 2017. PMID: 28599290.
  47. Williams RM, Tagai EK, Santos SLZ, Slade JL, Carter RL, Holt CL. The Role of Leadership Support in a Church-Based Cancer Education Implementation Study. J Relig Health. 2017. PMID: 28597333.
  48. Winckworth-Prejsnar K, Nardi EA, Lentz LK, Crawford JA, Fitzgerald CL, Carlson RW. Developments in Molecular Testing and Biosimilars. J Natl Compr Canc Netw. 2017;15(6):772-782. PMID: 28596257.
  49. Zaorsky NG, Davis BJ, Nguyen PL, et al. The Evolution of Brachytherapy for Prostate Cancer. Nat Rev Urol. 2017;14(7):415-439. PMID: 28664931.
  50. Zibelman M, Plimack ER. Integrating Immunotherapy into the Management of Renal Cell Carcinoma. J Natl Compr Canc Netw. 2017;15(6):841-847. PMID: 28596263.

Staff Publications: May 2017

Better late than never

  1. Aksoy MO, Kim V, Cornwell WD, et al. Secretion of the Endoplasmic Reticulum Stress Protein, Grp78, into the Balf Is Increased in Cigarette Smokers. Respir Res. 2017;18(1):78. PMID: 28464871. PMC5414124.
  2. Arora S, Huwe PJ, Sikder R, et al. Functional Analysis of Rare Variants in Mismatch Repair Proteins Augments Results from Computation-Based Predictive Methods. Cancer Biol Ther. 2017:0. PMID: 28494185.
  3. Baker N, Tong C, Simhan J. Reconstructive Management Options of Delayed Complications Following Bladder Outlet Surgery. Curr Urol Rep. 2017;18(4):27. PMID: 28247326.
  4. Benson AB, 3rd, D’Angelica MI, Abbott DE, et al. Nccn Guidelines Insights: Hepatobiliary Cancers, Version 1.2017. J Natl Compr Canc Netw. 2017;15(5):563-573. PMID: 28476736.
  5. Booij J, Dubroff J, Pryma D, et al. Diagnostic Performance of the Visual Reading of 123i-Ioflupane Spect Images When Assessed with or without Quantification in Patients with Movement Disorders or Dementia. J Nucl Med. 2017. PMID: 28473597.
  6. Brant JM, Rodgers BB, Gallagher E, Sundaramurthi T. Breakthrough Cancer Pain: A Systematic Review of Pharmacologic Management. Clin J Oncol Nurs. 2017;21(3):71-80. PMID: 28524907.
  7. Chang EI. Impact of Venous Outflow Tract on Survival of Osteocutaneous Free Fibula Flaps for Mandibular Reconstruction: A 14-Year Review. Head Neck. 2017. PMID: 28467662.
  8. Chu CS, Pfister DG. Opportunities and Challenges: Human Papillomavirus and Cancer. J Natl Compr Canc Netw. 2017;15(5s):726-729. PMID: 28515256.
  9. Chwistek M, Wolf M. Naloxone for Outpatients at Risk of Opioid Overdose #328. J Palliat Med. 2017;20(5):562-563.
  10. Cripe J, Handorf E, Brown J, Jain A, Rubin S, Mantia-Smaldone G. National Cancer Database Report of Lymphadenectomy Trends in Endometrial Cancer. Int J Gynecol Cancer. 2017. PMID: 28525495.
  11. Dickson A, Bailey CT, Karanicolas J. Optimal Allosteric Stabilization Sites Using Contact Stabilization Analysis. Journal of Computational Chemistry. 2017;38(15):1138-1146.
  12. Gallagher E, Rogers BB, Brant JM. Cancer-Related Pain Assessment: Monitoring the Effectiveness of Interventions. Clin J Oncol Nurs. 2017;21(3):8-12. PMID: 28524910.
  13. Ganti AK, Hirsch FR, Wynes MW, et al. Access to Cancer Specialist Care and Treatment in Patients with Advanced Stage Lung Cancer. Clin Lung Cancer. 2017. PMID: 28522158.
  14. Geynisman DM. Hope and Uncertainty in the Age of Miracles. J Palliat Med. 2017. PMID: 28520504.
  15. Geynisman DM, Plimack ER. Bending the Curve of Advanced Urothelial Carcinoma. J Oncol Pract. 2017;13(5):319-320. PMID: 28489979.
  16. Giroux V, Lento AA, Islam M, et al. Long-Lived Keratin 15+ Esophageal Progenitor Cells Contribute to Homeostasis and Regeneration. J Clin Invest. 2017;127(6):2378-2391. PMID: 28481227.
  17. Godwin JL, Jaggi S, Sirisena I, et al. Nivolumab-Induced Autoimmune Diabetes Mellitus Presenting as Diabetic Ketoacidosis in a Patient with Metastatic Lung Cancer. J Immunother Cancer. 2017;5:40. PMID: 28515940. PMC5433051.
  18. Gupta N, Brill JV, Canto M, et al. Aga White Paper: Training and Implementation of Endoscopic Image Enhancement Technologies. Clin Gastroenterol Hepatol. 2017;15(6):820-826. PMID: 28528939.
  19. Gupta S, Wang L, Kruger WD. The C.797 G>a (P.R266k) Cystathionine Beta-Synthase Mutation Causes Homocystinuria by Affecting Protein Stability. Hum Mutat. 2017. PMID: 28488385.
  20. Hoppe RT, Advani RH, Ai WZ, et al. Hodgkin Lymphoma Version 1.2017. JNCCN Journal of the National Comprehensive Cancer Network. 2017;15(5):608-638. PMID:
  21. Jadhav RR, Santucci-Pereira J, Wang YV, et al. DNA Methylation Targets Influenced by Bisphenol a and/or Genistein Are Associated with Survival Outcomes in Breast Cancer Patients. Genes (Basel). 2017;8(5). PMID: 28505145. PMC5448018.
  22. Jayadevappa R, Chhatre S, Wong YN, et al. Comparative Effectiveness of Prostate Cancer Treatments for Patient-Centered Outcomes: A Systematic Review and Meta-Analysis (Prisma Compliant). Medicine (United States). 2017;96(18).
  23. Jennings MC, Forman ME, Duggan SM, Minbiole KPC, Wuest WM. Efflux Pumps May Not Be the Major Drivers of Qac Resistance in Methicillin-Resistant Staphylococcus Aureus. Chembiochem. 2017. PMID: 28510317.
  24. Jiang Z, Slater CM, Zhou Y, et al. Lincin, a Novel Nf90-Binding Long Non-Coding Rna, Is Overexpressed in Advanced Breast Tumors and Involved in Metastasis. Breast Cancer Res. 2017;19(1):62. PMID: 28558830.
  25. Johnson DK, Karanicolas J. Computational Screening and Design for Compounds That Disrupt Protein-Protein Interactions. Curr Top Med Chem. 2017. PMID: 28482793.
  26. Kennedy PTF, Litwin S, Dolman GE, Bertoletti A, Mason WS. Immune Tolerant Chronic Hepatitis B: The Unrecognized Risks. Viruses. 2017;9(5). PMID: 28468285.
  27. Lawton CAF, Lin X, Hanks GE, et al. Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of Nrg Oncology Rtog 9202. Int J Radiat Oncol Biol Phys. 2017;98(2):296-303. PMID: 28463149.
  28. Marcinkiewicz C, Gerstenhaber JA, Sternberg M, Lelkes PI, Feuerstein G. Bitistatin-Functionalized Fluorescent Nanodiamond Particles Specifically Bind to Purified Human Platelet Integrin Receptor Alphaiibbeta3 and Activated Platelets. Int J Nanomedicine. 2017;12:3711-3720. PMID: 28553109. PMC5440039.
  29. McIntosh AG, Li T, Ito T, et al. Wbc Associates with Readmission Following Cystectomy. Bladder Cancer. 2017;3(2):95-103. PMID: 28516154. PMC5409152.
  30. Meyer JE, Finnberg NK, Chen L, et al. Tissue Tgf-Beta Expression Following Conventional Radiotherapy and Pulsed Low-Dose-Rate Radiation. Cell Cycle. 2017:1-4. PMID: 28486014.
  31. Michael JV, Wurtzel JGT, Mao GF, et al. Platelet Microparticles Infiltrating Solid Tumors Transfer Mirnas That Suppress Tumor Growth. Blood. 2017. PMID: 28500171.
  32. Miller-Halegoua SM. Why Null Results Do Not Mean No Results: Negative Findings Have Implications for Policy, Practice, and Research. Transl Behav Med. 2017. PMID: 28497323.
  33. Mirkin KA, Hollenbeak CS, Mohamed A, Jia Y, El-Deiry WS, Messaris E. Impact of Perineural Invasion on Survival in Node Negative Colon Cancer. Cancer Biol Ther. 2017:0. PMID: 28475454.
  34. Modi V, Sankararamakrishnan R. Binding Affinity of Pro-Apoptotic Bh3 Peptides for the Anti-Apoptotic Mcl-1 and A1 Proteins: Molecular Dynamics Simulations of Mcl-1 and A1 in Complex with Six Different Bh3 Peptides. Journal of Molecular Graphics & Modelling. 2017;73:115-128.
  35. Mortazavi SMJ, Mortazavi G, Paknahad M. Comment on Sundseth Et Al. Global Sources and Pathways of Mercury in the Context of Human Health. Int. J. Environ. Res. Public Health 2017, 14, 105. Int J Environ Res Public Health. 2017;14(5). PMID: 28475133.
  36. Nieborowska-Skorska M, Sullivan K, Dasgupta Y, et al. Gene Expression and Mutation-Guided Synthetic Lethality Eradicates Proliferating and Quiescent Leukemia Cells. J Clin Invest. 2017;127(6):2392-2406. PMID: 28481221.
  37. Patel D, Antwi J, Koneru PC, et al. A New Class of Allosteric Hiv-1 Integrase Inhibitors Identified by Crystallographic Fragment Screening of the Catalytic Core Domain. J Biol Chem. 2016;291(45):23569-23577. PMID: 27645997. PMC5095411.
  38. Perez-Guijarro E, Day CP, Merlino G, Zaidi MR. Genetically Engineered Mouse Models of Melanoma. Cancer. 2017;123(S11):2089-2103. PMID: 28543694. PMC5445933. NIHMS857850.
  39. Peshkova IO, Fatkhullina AR, Mikulski Z, Ley K, Koltsova EK. Il-27r Signaling Controls Myeloid Cells Accumulation and Antigen-Presentation in Atherosclerosis. Sci Rep. 2017;7(1):2255. PMID: 28536468. PMC5442117.
  40. Post CB, Levy RM. Editorial Overview: Theory & Computation. Curr Opin Struct Biol. 2017;43:iv-vi. PMID: 28477855.
  41. Ramamurthy C, Godwin JL, Borghaei H. Immune Checkpoint Inhibitor Therapy: What Line of Therapy and How to Choose? Curr Treat Options Oncol. 2017;18(6):33. PMID: 28534248.
  42. Reddy SS, Handorf B, Farma JM, Sigurdson ER. Trends with Neoadjuvant Radiotherapy and Clinical Staging for Those with Rectal Malignancies. World J Gastrointest Surg. 2017;9(4):97-102. PMID: 28503257. PMC5406733.
  43. Reese JB, Lepore SJ, Handorf E, Haythornthwaite JA. Emotional Approach Coping and Depressive Symptoms in Colorectal Cancer Patients: The Role of the Intimate Relationship. J Psychosoc Oncol. 2017:0. PMID: 28511030.
  44. Ross KC, Andrews AJ, Marion CD, Yen TJ, Bhattacharjee V. Identification of the Serine Biosynthesis Pathway as a Critical Component of Braf Inhibitor Resistance of Melanoma, Pancreatic, and Non-Small Cell Lung Cancer Cells. Mol Cancer Ther. 2017. PMID: 28500236.
  45. Saleh D, Najjar M, Zelic M, et al. Kinase Activities of Ripk1 and Ripk3 Can Direct Ifn-Beta Synthesis Induced by Lipopolysaccharide. J Immunol. 2017;198(11):4435-4447. PMID: 28461567.
  46. Sanchorawala V, Palladini G, Kukreti V, et al. A Phase 1/2 Study of the Oral Proteasome Inhibitor Ixazomib in Relapsed or Refractory Light-Chain (Al) Amyloidosis. Blood. 2017. PMID: 28550039.
  47. Scannell Bryan M, Argos M, Andrulis IL, et al. Limited Influence of Germline Genetic Variation on All-Cause Mortality in Women with Early Onset Breast Cancer: Evidence from Gene-Based Tests, Single-Marker Regression, and Whole-Genome Prediction. Breast Cancer Res Treat. 2017. PMID: 28503721.
  48. Schott AF, Goldstein L, Cristofanilli M, et al. Phase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly Paclitaxel in Patients with Her-2 Negative Metastatic Breast Cancer (Mbc). Clin Cancer Res. 2017. PMID: 28539464.
  49. Schrock AB, Li SD, Frampton GM, et al. Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling. Journal of Thoracic Oncology. 2017;12(6):932-942.
  50. Semenova G, Stepanova DS, Dubyk C, et al. Targeting Group I P21-Activated Kinases to Control Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis. Oncogene. 2017. PMID: 28534510.
  51. Shaikh T, Meyer JE, Horwitz EM. Optimal Use of Combined Modality Therapy in the Treatment of Esophageal Cancer. Surgical Oncology Clinics of North America. 2017.
  52. Skala E, Sitarek P, Toma M, et al. Inhibition of Human Glioma Cell Proliferation by Altered Bax/Bcl-2-P53 Expression and Apoptosis Induction by Rhaponticum Carthamoides Extracts from Transformed and Normal Roots. J Pharm Pharmacol. 2016;68(11):1454-1464. PMID: 27696406.
  53. Skalka A. Finding, Conducting, and Nurturing Science: A Virologist’s Memoir. Annu Rev Virol. 2017. PMID: 28548882.
  54. Solinski AE, Koval AB, Brzozowski RS, et al. Diverted Total Synthesis of Carolacton-Inspired Analogs Yields Three Distinct Phenotypes in Streptococcus Mutans Biofilms. J Am Chem Soc. 2017;139(21):7188-7191. PMID: 28502178.
  55. Tahrir FG, Knezevic T, Gupta MK, et al. Evidence for the Role of Bag3 in Mitochondrial Quality Control in Cardiomyocytes. J Cell Physiol. 2017;232(4):797-805. PMID: 27381181.
  56. Tahrir FG, Shanmughapriya S, Ahooyi TM, et al. Dysregulation of Mitochondrial Bioenergetics and Quality Control by Hiv-1 Tat in Cardiomyocytes. J Cell Physiol. 2017. PMID: 28493473.
  57. Upton JW, Shubina M, Balachandran S. Ripk3-Driven Cell Death During Virus Infections. Immunol Rev. 2017;277(1):90-101. PMID: 28462524.
  58. Wagner J, Kline CL, Ralff MD, et al. Preclinical Evaluation of the Imipridone Family, Analogues of Clinical Stage Anti-Cancer Small Molecule Onc201, Reveals Potent Anti-Cancer Effects of Onc212. Cell Cycle. 2017:0. PMID: 28489985.
  59. Waingankar N, Esnaola NF, Uzzo RG. A Structured Framework for Optimizing Surgical Quality through Process-of-Care Trials. Urologic Oncology-Seminars and Original Investigations. 2017;35(5):177-179.
  60. Weitzner BD, Jeliazkov JR, Lyskov S, et al. Modeling and Docking of Antibody Structures with Rosetta. Nat Protoc. 2017;12(2):401-416. PMID: 28125104.
  61. Yadav VK, Klein ML. Probing the Dynamics of N-Methylacetamide in Methanol Via Ab Initio Molecular Dynamics. Phys Chem Chem Phys. 2017;19(20):12868-12875. PMID: 28470307.
  62. Zhang J, Zhou L, Zhao S, Dicker DT, El-Deiry WS. The Cdk4/6 Inhibitor Palbociclib Synergizes with Irinotecan to Promote Colorectal Cancer Cell Death under Hypoxia. Cell Cycle. 2017:1-8. PMID: 28486050.
  63. Zhou C, Martinez E, Di Marcantonio D, et al. Jun Is a Key Transcriptional Regulator of the Unfolded Protein Response in Acute Myeloid Leukemia. Leukemia. 2017;31(5):1196-1205.

Staff Publications: April 2017

  1. Aggarwal C, Borghaei H. Treatment Paradigms for Advanced Non-Small Cell Lung Cancer at Academic Medical Centers: Involvement in Clinical Trial Endpoint Design. The Oncologist. 2017. PMID: 28408617.
  2. Allen RA, Jennings MC, Mitchell MA, Al-Khalifa SE, Wuest WM, Minbiole KPC. Ester- and Amide-Containing Multiqacs: Exploring Multicationic Soft Antimicrobial Agents. Bioorganic & Medicinal Chemistry Letters. 2017;27(10):2107-2112. PMID: 28392192.
  3. Bauman JE, Cohen E, Ferris RL, et al. Immunotherapy of Head and Neck Cancer: Emerging Clinical Trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting. Cancer. 2017;123(7):1259-1271. PMID: 27906454.
  4. Beck TN, Young NG, Erickson ML, Prats I. Rare Antibody-Associated Hemolytic Transfusion Reaction and Transfusion-Related Acute Lung Injury: A Case Report. BMC Surgery. 2017;17(1):48. PMID: 28441942. PMC5405478.
  5. Benson AB, III, Venook AP, Cederquist L, et al. Colon Cancer, Version 1.2017: Clinical Practice Guidelines in Oncology. JNCCN. 2017;15(3):370-398. PMID:28275037.
  6. Boushra M, Tous S, Fetih G, et al. Development and Evaluation of Viscosity-Enhanced Nanocarrier (Ven) for Oral Insulin Delivery. International Journal of Pharmaceutics. 2016;511(1):462-472. PMID: 27418563.
  7. Brzozowski RS, Wuest WM. Twelve-Membered Macrolactones: Privileged Scaffolds for the Development of New Therapeutics. Chemical Biology & Drug Design. 2017;89(2):169-191. PMID: 27153932.
  8. Cagney DN, Martin AM, Catalano PJ, et al. Incidence and Prognosis of Patients with Brain Metastases at Diagnosis of Systemic Malignancy: A Population-Based Study. Neuro-oncology. 2017. PMID: 28444227.
  9. Carraro M, Minervini G, Giollo M, et al. Performance of in Silico Tools for the Evaluation of P16ink4a (Cdkn2a) Variants in Cagi. Human Mutation. 2017. PMID: 28440912.
  10. Chang HW, Studitsky VM. Chromatin Replication: Transmitting the Histone Code. Journal of nature and science. 2017;3(2). PMID: 28393112. PMC5384335.
    Chatare VK, Andrade RB. Total Synthesis of (-)-Albocycline. Angewandte Chemie (International ed in English). 2017. PMID: 28429505.
  11. Coleman RL, Brady MF, Herzog TJ, et al. Bevacizumab and Paclitaxel-Carboplatin Chemotherapy and Secondary Cytoreduction in Recurrent, Platinum-Sensitive Ovarian Cancer (Nrg Oncology/Gynecologic Oncology Group Study Gog-0213): A Multicentre, Open-Label, Randomised, Phase 3 Trial. The Lancet Oncology. 2017. PMID: 28438473.
  12. Darlow S, Heckman C. Results from a Tailored Sms and Behavior-Tracking Pilot Study on Sun-Safe Behaviors in Young Women. Health Education & Behavior. 2017:1090198117699507. PMID: 28363246.
  13. Deneka AY, Haber L, Kopp MC, Gaponova AV, Nikonova AS, Golemis EA. Tumor-Targeted Sn38 Inhibits Growth of Early Stage Non-Small Cell Lung Cancer (Nsclc) in a Kras/P53 Transgenic Mouse Model. PLoS One. 2017;12(4):e0176747. PMID: 28453558.
  14. Dias MF, Blumenstein R, Russo J. Use of Laser Capture Microdissection Allows Detection of Loss of Heterozygosity in Chromosome 9p in Breast Cancer. Oncology Letters. 2017;13(5):3831-3836.
  15. Escudier B, Motzer RJ, Sharma P, et al. Treatment Beyond Progression in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab in Checkmate 025. European Urology. 2017. PMID: 28410865.
  16. Ettinger DS, Wood DE, Aisner DL, et al. Non-Small Cell Lung Cancer, Version 5.2017: Clinical Practice Guidelines in Oncology. JNCCN. 2017;15(4):504-535. PMID: 28404761
  17. Flynn WF, Haldane A, Torbett BE, Levy RM. Inference of Epistatic Effects Leading to Entrenchment and Drug Resistance in Hiv-1 Protease. Molecular Biology and Evolution. 2017. PMID: 28369521.
  18. Gerson JN, Skariah S, Denlinger CS, Astsaturov I. Perspectives of Her2-Targeting in Gastric and Esophageal Cancer. Expert Opinion on Investigational Drugs. 2017;26(5):531-540. PMID: 28387541.
  19. Golan S, Johnson SC, Maurice MJ, et al. Safety and Early Effectiveness of Robot-Assisted Partial Nephrectomy for Large Angiomyolipomas. BJU International. 2017;119(5):755-760. PMID: 27988984
  20. Gordon RE, Zhang L, Yang ZJ. Restore the Brake on Tumor Progression. Biochemical Pharmacology. 2017. PMID: 28389227.
  21. Gore JL, Plessis MD, Santiago-Jimenez M, et al. Decipher Test Impacts Decision Making among Patients Considering Adjuvant and Salvage Treatment after Radical Prostatectomy: Interim Results from the Multicenter Prospective Pro-Impact Study. Cancer. 2017. PMID: 28422278.
  22. Gradishar WJ, Anderson BO, Balassanian R, et al. NCCN Guidelines® Insights Breast Cancer, Version 1.2017: Featured Updates to the NCCN Guidelines. JNCCN. 2017;15(4):433-451. PMID: 28404755
  23. Haifler M, Kutikov A. Current Role of Renal Biopsy in Urologic Practice. The Urologic Clinics of North America. 2017;44(2):203-211. PMID: 28411912.
  24. Haldane A, Flynn WF, He P, Vijayan RS, Levy RM. Structural Propensities of Kinase Family Proteins from a Potts Model of Residue Co-Variation. Protein Science. 2016;25(8):1378-1384. PMID: 27241634. PMC4972195.
  25. Heckman CJ, Handorf EA, Darlow SD, Ritterband LM, Manne SL. An Online Skin Cancer Risk-Reduction Intervention for Young Adults: Mechanisms of Effects. Health Psychology. 2017;36(3):215-225. PMID: 27819460. PMCID: PMC5328853
  26. Infante JR, Cohen RB, Kim KB, et al. A Phase I Dose-Escalation Study of Selumetinib in Combination with Erlotinib or Temsirolimus in Patients with Advanced Solid Tumors. Investigational New Drugs. 2017. PMID: 28424891.
  27. Jiang W, Dulaimi E, Devarajan K, et al. Intratumoral Heterogeneity Analysis Reveals Hidden Associations between Protein Expression Losses and Patient Survival in Clear Cell Renal Cell Carcinoma. Oncotarget. 2017. PMID: 28445125.
  28. Joshi SS, Uzzo RG. Renal Tumor Anatomic Complexity: Clinical Implications for Urologists. The Urologic Clinics of North America. 2017;44(2):179-187. PMID: 28411910.
  29. Jung S, Allen N, Arslan AA, et al. Demographic, Lifestyle, and Other Factors in Relation to Antimullerian Hormone Levels in Mostly Late Premenopausal Women. Fertility and Sterility. 2017;107(4):1012-1022.e1012. PMID: 28366409.
  30. Klein-Szanto AJ, Bassi DE. Proprotein Convertase Inhibition: Paralyzing the Cell’s Master Switches. Biochemical Pharmacology. 2017. PMID: 28456517.
  31. Kumar SK, Callander NS, Alsina M, et al. Multiple Myeloma, Version 3.2017 Clinical Practice Guidelines in Oncology. JNCCN. 2017;15(2):230-+. PMID: 28188192
  32. Kutikov A, Smaldone MC. The Small Renal Mass and Its Management in Urologic Practice. The Urologic Clinics of North America. 2017;44(2):xvii. PMID: 28411925.
  33. Lawler AC, Ghiraldi EM, Tong C, Friedlander JI. Extracorporeal Shock Wave Therapy: Current Perspectives and Future Directions. Current Urology Reports. 2017;18(4). PMID: 28247327
  34. Lee HO, Uzzo RG, Kister D, Kruger WD. Combination of Serum Histidine and Plasma Tryptophan as a Potential Biomarker to Detect Clear Cell Renal Cell Carcinoma. Journal of Translational Medicine. 2017;15(1):72. PMID: 28385150. PMC5383954.
  35. Li PD, Hu JL, Ma C, et al. Upregulation of the Long Non-Coding Rna Pvt1 Promotes Esophageal Squamous Cell Carcinoma Progression by Acting as a Molecular Sponge of Mir-203 and Lasp1. Oncotarget. 2017. PMID: 28404954.
  36. Liederbach E, Kyrillos A, Wang CH, Liu JC, Sturgis EM, Bhayani MK. The National Landscape of Human Papillomavirus-Associated Oropharynx Squamous Cell Carcinoma. International Journal of Cancer. 2017;140(3):504-512. PMID: 27667729.
  37. Longacre ML, Valdmanis VG, Handorf EA, Fang CY. Work Impact and Emotional Stress among Informal Caregivers for Older Adults. The Journals of Gerontology Series B, Psychological Sciences and Social Sciences. 2017;72(3):522-531. PMID: 27048567.
  38. Lupey-Green LN, Moquin SA, Martin KA, et al. Parp1 Restricts Epstein Barr Virus Lytic Reactivation by Binding the Bzlf1 Promoter. Virology. 2017;507:220-230. PMID: 28456021.
  39. Lynch SM, Mitra N, Ravichandran K, et al. Telomere Length and Neighborhood Circumstances: Evaluating Biological Response to Unfavorable Exposures. Cancer Epidemiology, Biomarkers & Prevention. 2017;26(4):553-560. PMID: 28373169.
  40. Meng Y, Cai KQ, Moore R, et al. Pten Facilitates Epiblast Epithelial Polarization and Proamniotic Lumen Formation in Early Mouse Embryos. Developmental Dynamics. 2017. PMID: 28387983.
  41. Miller MP, Kostakoglu L, Pryma D, et al. Reader Training for the Re-Staging of Biochemically Recurrent Prostate Cancer Using Fluciclovine (18f) Pet/Ct. Journal of Nuclear Medicine. 2017. PMID: 28385791.
  42. Moore KN, Borghaei H, O’Malley DM, et al. Phase 1 Dose-Escalation Study of Mirvetuximab Soravtansine (Imgn853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Patients with Solid Tumors. Cancer. 2017. PMID: 28440955.
  43. Moore KN, Martin LP, O’Malley DM, et al. Safety and Activity of Mirvetuximab Soravtansine (Imgn853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study. Journal of Clinical Oncology. 2017; 35(10):1112-1118. PMID: 28029313
  44. Mortazavi SMJ, Zarei S, Taheri M, et al. Sensitivity to Antibiotics of Bacteria Exposed to Gamma Radiation Emitted from Hot Soils of the High Background Radiation Areas of Ramsar, Northern Iran. The International Journal of Occupational and Environmental Medicine. 2017;8(2):80-84. PMID: 28432369.
  45. Necchi A, Pond GR, Smaldone MC, et al. Robot-Assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-Invasive Bladder Cancer: The Oncologist’s Perspective from a Multicentre Study. European Urology Focus. 2017.
  46. Nizovtseva EV, Clauvelin N, Todolli S, et al. Nucleosome-Free DNA Regions Differentially Affect Distant Communication in Chromatin. Nucleic Acids Research. 2017;45(6):3059-3067. PMID: 27940560. PMCID: PMC5389534
  47. Obeid EI, Hall MJ, Daly MB. Multigene Panel Testing and Breast Cancer Risk: Is It Time to Scale Down? JAMA Oncology. 2017. PMID: 28418452.
  48. Pazina T, Shemesh A, Brusilovsky M, Porgador A, Campbell KS. Regulation of the Functions of Natural Cytotoxicity Receptors by Interactions with Diverse Ligands and Alterations in Splice Variant Expression. Frontiers in Immunology. 2017;8:369. PMID: 28424697. PMC5371597.
  49. Ragin C, Liu JC, Jones G, et al. Prevalence of HPV Infection in Racial-Ethnic Subgroups of Head and Neck Cancer Patients. Carcinogenesis. 2017;38(2):218-229.
  50. Ralff MD, Kline CLB, Kucukkase OC, et al. Onc201 Demonstrates Anti-Tumor Effects in Both Triple Negative and Non-Triple Negative Breast Cancers through Trail-Dependent and Trail-Independent Mechanisms. Molecular cancer therapeutics. 2017. PMID: 28424227.
  51. Reese JB, Beach MC, Smith KC, et al. Effective Patient-Provider Communication About Sexual Concerns in Breast Cancer: A Qualitative Study. Supportive Care in Cancer. 2017. PMID: 28451911.
  52. Ristau BT, Correa AF, Uzzo RG, Smaldone MC. Active Surveillance for the Small Renal Mass: Growth Kinetics and Oncologic Outcomes. The Urologic clinics of North America. 2017;44(2):213-222. PMID: 28411913.
  53. Ristau BT, Kutikov A, Uzzo RG, Smaldone MC. Active Surveillance for Small Renal Masses: When Less Is More. European Urology Focus. 2017.
  54. Roche LM, Niu X, Stroup AM, Henry KA. Disparities in Female Breast Cancer Stage at Diagnosis in New Jersey: A Spatial-Temporal Analysis. JPHMP. 2016. PMID: 28430705.
  55. Saribas AS, Coric P, Hamazaspyan A, et al. Emerging from the Unknown: Structural and Functional Features of Agnoprotein of Polyomaviruses. Journal of Cellular Physiology. 2016;231(10):2115-2127. PMID: 26831433. PMC5217748.
  56. Segal S, John G, Sammel M, et al. Urinary Incontinence and Other Pelvic Floor Disorders after Radiation Therapy in Endometrial Cancer Survivors. Maturitas. 2017. PMID: 28396018.
  57. Smaldone MC, Egleston B, Hollingsworth JM, et al. Understanding Treatment Disconnect and Mortality Trends in Renal Cell Carcinoma Using Tumor Registry Data. Medical Care. 2017;55(4):398-404. PMID: 27820596. PMCID: PMC5352513.
  58. Soni RS, Ebersole B, Jamal N. Does Even Low-Grade Dysphonia Warrant Voice Center Referral? Journal of Voice. 2017. PMID: 28396220.
  59. Tong C, Daskalakis N, Edwards DC, Cahn DB, Belkoff L, Geynisman DM. Malignant Infiltration of the Penis from Urothelial Carcinoma of the Bladder. Urology. 2017. PMID: 28373110.
  60. Waldorf B, Lee Z, Kidd L, et al. Robotic Buccal Ureteroplasty: A Review of the Current Literature. Current Urology Reports. 2017;18(5):40. PMID: 28401476.
  61. Wei S, Layfield LJ, LiVolsi VA, Montone KT, Baloch ZW. Reporting of Fine Needle Aspiration (Fna) Specimens of Salivary Gland Lesions: A Comprehensive Review. Diagnostic Cytopathology. 2017. PMID: 28371507.
  62. Weidhaas JB, Harris J, Schaue D, et al. The Kras-Variant and Cetuximab Response in Head and Neck Squamous Cell Cancer: A Secondary Analysis of a Randomized Clinical Trial. JAMA Oncology. 2017;3(4):483-491. PMID: 28006059.
  63. Weinberg DS, Lin JE, Foster NR, et al. Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention. Cancer Prevention Research (Philadelphia, PA). 2017. PMID: 28396341.
  64. Weng YL, An R, Cassin J, et al. An Intrinsic Epigenetic Barrier for Functional Axon Regeneration. Neuron. 2017;94(2):337-346.e336. PMID: 28426967.
  65. Whelan KA, Chandramouleeswaran PM, Tanaka K, et al. Autophagy Supports Generation of Cells with High Cd44 Expression Via Modulation of Oxidative Stress and Parkin-Mediated Mitochondrial Clearance. Oncogene. 2017. PMID: 28414310.
  66. Wierda WG, Zelenetz AD, Gordon LI, et al. NCCN Guidelines® Insights Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017: Featured Updates to the NCCN Guidelines. JNCCN. 2017;15(3):293-311. PMID: 28275031
  67. Xi H, Zhang Y, Xu Y, et al. Caspase-1 Inflammasome Activation Mediates Homocysteine-Induced Pyrop-Apoptosis in Endothelial Cells. Circulation research. 2016;118(10):1525-1539. PMID: 27006445. PMC4867131.
  68. Xu Q, Tang Q, Katsonis P, et al. Benchmarking Predictions of Allostery in Liver Pyruvate Kinase in Cagi4. Human Mutation. 2017. PMID: 28370845.
  69. Xue J, McKay JD, Grimm J, et al. Small-Field Dose Measurements Using Plastic Scintillation Detector in Heterogeneous Media. Medical physics. 2017. PMID: 28398596.
  70. Yoo SK, Ahmed AA, Ileto J, et al. Industry Funding among Leadership in Medical Oncology and Radiation Oncology in 2015. International Journal of Radiation Oncology, Biology, Physics. 2017. PMID: 28366578.
  71. Younes A, Hilden P, Coiffier B, et al. International Working Group Consensus Response Evaluation Criteria in Lymphoma (Recil 2017). Annals of Oncology. 2017. PMID: 28379322.
  72. Zaorsky NG, Churilla TM, Egleston BL, et al. Causes of Death among Cancer Patients. Annals of Oncology. 2017;28(2):400-407.

Two things of note. If your research was funded, in full or in part, by the Core Grant you must acknowledge the Core Grant in your paper. For examples of how to acknoweldge grant funding from the NIH, NSF, HHS, and other grantors see the Acknowledging Grant Funding tab of our NIH Public Access Compliance guide. Finally, unless the publisher deposits articles with the NIHMS (NIH Manuscript Submission System) for inclusion in PubMed Central, the primary author (or designated delegate) is responsible for depositing the final approved manuscript and all tables and images with the NIHMS. Do not deposit the publisher’s PDF with the NIHMS, as that is the publisher’s property. Elsevier, Wiley, JAMA, BMJ may deposit their PDFs as they see fit, you the author, however, may not. For instructions on how to deposit a manuscript with the NIHMS, see the NIH Public Access Compliance guide.

Staff Publications: March 2017

  1. Arvold ND, Pinnell NE, Mahadevan A, et al. Steroid and Anticonvulsant Prophylaxis for Stereotactic Radiosurgery: Large Variation in Physician Recommendations. Practical radiation oncology. 2016;6(4):e89-96. PMID: 26850650.
  2. Baker N, Tong C, Simhan J. Reconstructive Management Options of Delayed Complications Following Bladder Outlet Surgery. Current urology reports. 2017;18(4):27. PMID: 28247326.
  3. Bartel MJ, Raimondo M. Endoscopic Management of Pancreatic Cysts. Digestive diseases and sciences. 2017. PMID: 28315030.
  4. Bazzoli A, Karanicolas J. “Solvent Hydrogen-Bond Occlusion”: A New Model of Polar Desolvation for Biomolecular Energetics. Journal of computational chemistry. 2017. PMID: 28318014.
  5. Berger ER, Wang CE, Kaufman CS, et al. National Accreditation Program for Breast Centers Demonstrates Improved Compliance with Post-Mastectomy Radiation Therapy Quality Measure. Journal of the American College of Surgeons. 2017;224(3):236-244.
  6. Bingham C, Fernandez SV, Fittipaldi P, et al. Mutational Studies on Single Circulating Tumor Cells Isolated from the Blood of Inflammatory Breast Cancer Patients. Breast cancer research and treatment. 2017. PMID: 28271309.
  7. Campbell SC, Dong W, Uzzo R, Kutikov A. Re: Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma. European urology. 2017;71(3):495-495.
  8. Dong Y, Ruth KJ, Churilla TM, et al. The Need for Androgen Deprivation Therapy in Patients with Intermediate-Risk Prostate Cancer Treated with Dose-Escalated External Beam Radiation Therapy. The Canadian journal of urology. 2017;24(1):8656-8662. PMID: 28263132.
  9. Escudier B, Sharma P, McDermott DF, et al. Checkmate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma. European urology. 2017. PMID: 28262413.
  10. Esnaola NF, Meyer JE, Karachristos A, Maranki JL, Camp ER, Denlinger CS. Evaluation and Management of Intrahepatic and Extrahepatic Cholangiocarcinoma. Cancer. 2016;122(9):1349-1369. PMID: 26799932.
  11. Gaponova AV, Deneka AY, Beck TN, et al. Identification of Evolutionarily Conserved DNA Damage Response Genes That Alter Sensitivity to Cisplatin. Oncotarget. 2017;8(12):19156-19171.
  12. Geynisman DM, de Velasco G, Sewell KL, Jacobs I. Biosimilar Biologic Drugs: A New Frontier in Medical Care. Postgraduate medicine. 2017. PMID: 28343424.
  13. Grove M, Kim H, Santerre M, et al. Yap/Taz Initiate and Maintain Schwann Cell Myelination. Elife. 2017;6. PMID: 28124973. PMC5287714.
  14. Haas NB, Manola J, Dutcher JP, et al. Adjuvant Treatment for High-Risk Clear Cell Renal Cancer: Updated Results of a High-Risk Subset of the Assure Randomized Trial. JAMA oncology. 2017. PMID: 28278333.
  15. Haifler M, Kutikov A. Update on Renal Mass Biopsy. Current urology reports. 2017;18(4):28. PMID: 28251484.
  16. Hensley H, Cooper HS, Chang WL, Clapper ML. Imaging Matrix Metalloproteases in Spontaneous Colon Tumors: Validation by Correlation with Histopathology. Methods in molecular biology (Clifton, NJ). 2017;1579:245-255. PMID: 28299741.
  17. Huang Q, He S, Tian Y, et al. Hsp90 Inhibition Destabilizes Ezh2 Protein in Alloreactive T Cells and Reduces Graft-Versus-Host Disease in Mice. Blood. 2017. PMID: 28246193.
  18. Hurwitz MD, Harris J, Sartor O, et al. Adjuvant Radiation Therapy, Androgen Deprivation, and Docetaxel for High-Risk Prostate Cancer Postprostatectomy: Results of Nrg Oncology/Rtog Study 0621. Cancer. 2017. PMID: 28323339.
  19. Kennedy AS, Ball D, Cohen SJ, et al. Baseline Hemoglobin and Liver Function Predict Tolerability and Overall Survival of Patients Receiving Radioembolization for Chemotherapy-Refractory Metastatic Colorectal Cancer. Journal of gastrointestinal oncology. 2017;8(1):70-80. PMID: 28280611. PMC5334043.
  20. Kennedy PT, Bertoletti A, Mason WS. Reply. Gastroenterology. 2017;152(5):1246-1247. PMID: 28273438.
  21. Korobeynikov V, Deneka AY, Golemis EA. Mechanisms for Nonmitotic Activation of Aurora-a at Cilia. Biochemical Society Transactions. 2017;45(1):37-39. PMID:
  22. Lawler AC, Ghiraldi EM, Tong C, Friedlander JI. Extracorporeal Shock Wave Therapy: Current Perspectives and Future Directions. Current urology reports. 2017;18(4):25. PMID: 28247327.
  23. Leroy B, Ballinger ML, Baran-Marszak F, et al. Recommended Guidelines for Validation, Quality Control, and Reporting of Tp53 Variants in Clinical Practice. Cancer research. 2017;77(6):1250-1260. PMID: 28254861.
  24. Liu HL, Huang BY, Zhang MS, Wang HR, Qu YM, Yu CJ. Sellar and Suprasellar Granular Cell Tumor of Neurohypophysis. Chinese medical journal. 2017;130(6):741-743. PMID: 28303860.
  25. LoRusso PM, Infante JR, Kim KB, et al. A Phase I Dose-Escalation Study of Selumetinib in Combination with Docetaxel or Dacarbazine in Patients with Advanced Solid Tumors. BMC cancer. 2017;17(1):173. PMID: 28264648. PMC5340007.
  26. Lynch SM, Mitra N, Ross M, et al. A Neighborhood-Wide Association Study (Nwas): Example of Prostate Cancer Aggressiveness. PloS one. 2017;12(3):e0174548. PMID: 28346484.
  27. Merza H, Bilusic M. Current Management Strategy for Metastatic Renal Cell Carcinoma and Future Directions. Current oncology reports. 2017;19(4):27. PMID: 28303494.
  28. Mullinax JE, Kroon HM, Thompson JF, et al. Isolated Limb Infusion as a Limb Salvage Strategy for Locally Advanced Extremity Sarcoma. J Am Coll Surg. 2017;224(4):635-642. PMID: 28214556.
  29. Mustian KM, Alfano CM, Heckler C, et al. Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue: A Meta-Analysis. JAMA oncology. 2017. PMID: 28253393.
  30. Naito S, Makhov P, Astsaturov I, et al. Ldl Cholesterol Counteracts the Antitumour Effect of Tyrosine Kinase Inhibitors against Renal Cell Carcinoma. British journal of cancer. 2017. PMID: 28350788.
  31. Necchi A, Pond GR, Raggi D, et al. Clinical Outcomes of Perioperative Chemotherapy in Patients with Locally Advanced Penile Squamous-Cell Carcinoma: Results of a Multicenter Analysis. Clinical genitourinary cancer. 2017. PMID: 28325636.
  32. Peri S, Caretti E, Tricarico R, et al. Haploinsufficiency in Tumor Predisposition Syndromes: Altered Genomic Transcription in Morphologically Normal Cells Heterozygous for Vhl or Tsc Mutation. Oncotarget. 2017;8(11):17628-17642.
  33. Phelan CM, Kuchenbaecker KB, Tyrer JP, et al. Identification of 12 New Susceptibility Loci for Different Histotypes of Epithelial Ovarian Cancer. Nature genetics. 2017. PMID: 28346442.
  34. Pinheiro PS, Callahan KE, Ragin C, Hage RW, Hylton T, Kobetz EN. Black Heterogeneity in Cancer Mortality: Us-Blacks, Haitians, and Jamaicans. Cancer control : journal of the Moffitt Cancer Center. 2016;23(4):347-358. PMID: 27842324. PMC5321133.
  35. Pollack A, Kwon D, Walker G, et al. Prospective Validation of Diagnostic Tumor Biomarkers in Men Treated with Radiotherapy for Prostate Cancer. Jnci-Journal of the National Cancer Institute. 2017;109(2). PMID: WOS:000396774100009.
  36. Prabhu VV, Hong B, Allen JE, et al. Small-Molecule Prodigiosin Restores P53 Tumor Suppressor Activity in Chemoresistant Colorectal Cancer Stem Cells Via C-Jun-Mediated Deltanp73 Inhibition and P73 Activation. Cancer research. 2016;76(7):1989-1999. PMID: 26759239.
  37. Raynal NJ, Da Costa EM, Lee JT, et al. Repositioning Fda-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer Epigenome. Molecular cancer therapeutics. 2017;16(2):397-407. PMID: 27980103. PMC5292054.
  38. Rimm DL, Han G, Taube JM, et al. A Prospective, Multi-Institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for Pd-L1 Expression in Non-Small Cell Lung Cancer. JAMA oncology. 2017. PMID: 28278348.
  39. Ristau BT, Smaldone MC. Kidney Cancer: Emerging Guidelines for Managing Small Renal Masses. Nature reviews Urology. 2017. PMID: 28290457.
  40. Schootman M, Gomez SL, Henry KA, et al. Geospatial Approaches to Cancer Control and Population Sciences. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2017. PMID: 28325736.
  41. Schrock AB, Li SD, Frampton GM, et al. Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2017. PMID: 28315738.
  42. Stein MN, Bertino JR, Kaufman HL, et al. First-in-Human Clinical Trial of Oral Onc201 in Patients with Refractory Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017. PMID: 28331050.
  43. Stroup AM, Herget KA, Hanson HA, et al. Baby Boomers and Birth Certificates: Early-Life Socioeconomic Status and Cancer Risk in Adulthood. Cancer Epidemiology Biomarkers & Prevention. 2017;26(1):75-84.
  44. Tokar JJ, Warrick JW, Guckenberger DJ, et al. Interrogating Bronchoalveolar Lavage Samples Via Exclusion-Based Analyte Extraction. SLAS technology. 2017:2472630317696780. PMID: 28298147.
  45. Traino HM, Siminoff LA. Keep It Going: Maintaining Health Conversations Using Relational and Instrumental Approaches. Health communication. 2016;31(3):308-319. PMID: 26325602.
  46. van Vulpen M, Wang L. Within the Next Five Years, Adaptive Hypofractionation Will Become the Most Common Form of Radiotherapy. Medical physics. 2016;43(7):3941. PMID: 27370112.
  47. Volokh OI, Derkacheva NI, Studitsky VM, Sokolova OS. [Structural Studies of Chromatin Remodeling Factors]. Molekuliarnaia biologiia. 2016;50(6):922-934. PMID: 28064308.
  48. Wang Y, Santerre M, Tempera I, Martin K, Mukerjee R, Sawaya BE. Hiv-1 Vpr Disrupts Mitochondria Axonal Transport and Accelerates Neuronal Aging. Neuropharmacology. 2017;117:364-375. PMID: 28212984.
  49. Wei S, LiVolsi VA, Montone KT, Morrissette JJ, Baloch ZW. Detection of Molecular Alterations in Medullary Thyroid Carcinoma Using Next-Generation Sequencing: An Institutional Experience. Endocrine pathology. 2016;27(4):359-362. PMID: 27379493.
  50. Wierda WG, Zelenetz AD, Gordon LI, et al. Nccn Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017. Journal of the National Comprehensive Cancer Network : JNCCN. 2017;15(3):293-311. PMID: 28275031.
  51. Wiest DL. Themis-Tery Is Solved. Nature immunology. 2017;18(4):368-370. PMID: 28323266.
  52. Yoon SM, Shaikh T, Hallman M. Therapeutic Management Options for Stage Iii Non-Small Cell Lung Cancer. World journal of clinical oncology. 2017;8(1):1-20. PMID: 28246582. PMC5309711.
  53. Zaorsky NG, Ricco AG, Churilla TM, Horwitz EM, Den RB. Astro Apex(R) and Ro-Ils Are Applicable to Medical Malpractice in Radiation Oncology. Future oncology (London, England). 2016;12(22):2643-2657. PMID: 27470145.
  54. Zaorsky NG, Showalter TN, Ezzell GA, et al. Acr Appropriateness Criteria® External Beam Radiation Therapy Treatment Planning for Clinically Localized Prostate Cancer, Part I of Ii. Advances in Radiation Oncology. 2017;2(1):62-84.
  55. Zawistowski JS, Bevill SM, Goulet DR, et al. Enhancer Remodeling During Adaptive Bypass to Mek Inhibition Is Attenuated by Pharmacologic Targeting of the P-Tefb Complex. Cancer discovery. 2017;7(3):302-321. PMID: 28108460. PMC5340640.
  56. Zhang FF, Haslam DE, Terry MB, et al. Dietary Isoflavone Intake and All-Cause Mortality in Breast Cancer Survivors: The Breast Cancer Family Registry. Cancer. 2017. PMID: 28263368.
  57. Zijoo R, von Mehren M. Efficacy of Trabectedin for the Treatment of Liposarcoma. Expert opinion on pharmacotherapy. 2016;17(14):1953-1962. PMID: 27615729.

Staff Publications: February 2017

1.    van Esterik JC, Vitins AP, Hodemaekers HM, et al. Liver DNA Methylation Analysis in Adult Female C57bl/6jxfvb Mice Following Perinatal Exposure to Bisphenol A. Toxicology Letters. 2015;232(1):293-300. PMID: 25455458.

2.    Conn KM, Fisher SG, Rhee H. Parent and Child Independent Report of Emotional Responses to Asthma-Specific Vignettes: The Relationship between Emotional States, Self-Management Behaviors, and Symptoms. Journal of Pediatric Nursing. 2016;31(2):e83-90. PMID: 26711704.

3.    Koshkareva Y, Liu JC, Lango M, Galloway T, Gaughan JP, Ridge JA. Cervical Metastasis in Squamous Cell Carcinoma of the Hard Palate and Maxillary Alveolus. Ear, Nose and Throat Journal. 2016;95(10-11):E6.

4.    Zuniga S, Ebersole B, Jamal N. Inpatient Injection Laryngoplasty for Vocal Fold Immobility: When Is It Really Necessary? American Journal of Otolaryngology – Head and Neck Medicine and Surgery. 2016.

5.    Abbosh P, Sundararajan S, Millis SZ, et al. Molecular and Genomic Profiling to Identify Actionable Targets in Chromophobe Renal Cell Cancer. European Urology Focus. 2017.

6.    Biermann JS, Chow W, Reed DR, et al. Nccn Guidelines Insights: Bone Cancer, Version 2.2017. Journal of the National Comprehensive Cancer Network : JNCCN. 2017;15(2):155-167. PMID: 28188186.

7.    Burstein HJ, Krilov L, Aragon-Ching JB, et al. Clinical Cancer Advances 2017: Annual Report on Progress against Cancer from the American Society of Clinical Oncology. Journal of Clinical Oncology : official journal of the American Society of Clinical Oncology. 2017:Jco2016715292. PMID: 28148207.

8.    Chang WL, Masih S, Thadi A, et al. Plecanatide-Mediated Activation of Guanylate Cyclase-C Suppresses Inflammation-Induced Colorectal Carcinogenesis in Apc+/Min-Fccc Mice. World Journal of Gastrointestinal Pharmacology and Therapeutics. 2017;8(1):47-59. PMID: 28217374. PMC5292606.

9.    Chernoff J. Alfred G. Knudson Jr, Md, Phd: In Memoriam (1922-2016). Cancer Research. 2017;77(4):815-816. PMID: 28202462.

10.    Christian AH, O’Malley D, Barac A, Miller SM, Hudson SV. Cardiovascular Risk and Communication among Early Stage Breast Cancer Survivors. Patient Education and Counseling. 2017. PMID: 28215826.

11.    Darlow SD, Heckman CJ, Munshi T, Collins BN. Thirdhand Smoke Beliefs and Behaviors among Healthcare Professionals. Psychology, Health & Medicine. 2017;22(4):415-424.

12.    Daugherty M, Sedaghatpour D, Shapiro O, Vourganti S, Kutikov A, Bratslavsky G. The Metastatic Potential of Renal Tumors: Influence of Histologic Subtypes on Definition of Small Renal Masses, Risk Stratification, and Future Active Surveillance Protocols. Urologic Oncology. 2017. PMID: 28202224.

13.    Ghatalia P, Zibelman M, Geynisman DM, Plimack ER. Checkpoint Inhibitors for the Treatment of Renal Cell Carcinoma. Current Treatment Options in Oncology. 2017;18(1):7. PMID: 28210995.

14.    Goldfinger LE, Michael JV. Regulation of Ras Signaling and Function by Plasma Membrane Microdomains. Bioscience Trends. 2017. PMID: 28179601.

15.    Greenberg PL, Stone RM, Al-Kali A, et al. Myelodysplastic Syndromes, Version 2.2017 Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network: JNCCN. 2017;15(1):60-87.

16.    Hamdi Y, Soucy P, Kuchenbaeker KB, et al. Association of Breast Cancer Risk in Brca1 and Brca2 Mutation Carriers with Genetic Variants Showing Differential Allelic Expression: Identification of a Modifier of Breast Cancer Risk at Locus 11q22.3. Breast Cancer Research and Treatment. 2017;161(1):117-134.

17.    Heckman CJ, Handorf E, Darlow SD, Yaroch AL, Raivitch S. Refinement of Measures to Assess Psychosocial Constructs Associated with Skin Cancer Risk and Protective Behaviors of Young Adults. Journal of Behavioral Medicine. 2017. PMID: 28155000.

18.    Heinrich M, Rankin C, Blanke CD, et al. Correlation of Long-Term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors with Next-Generation Sequencing Results: Analysis of Phase 3 Swog Intergroup Trial S0033. JAMA Oncology. 2017. PMID: 28196207.

19.    Joshi S, Kutikov A. Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment Editorial Comment. Journal of Urology. 2017;197(2):383-384.

20.    Joshi SS, Chen DYT. Extended Duration Enoxaparin Decreases the Rate of Venous Thromboembolic Events after Radical Cystectomy Compared to Inpatient Only Subcutaneous Heparin Editorial Comment. Journal of Urology. 2017;197(2):307-307.

21.    Kayser K, Acquati C, Reese JB, Mark K, Wittmann D, Karam E. A Systematic Review of Dyadic Studies Examining Relationship Quality in Couples Facing Colorectal Cancer Together. Psycho-Oncology. 2017:No Pagination Specified.

22.    Khayati K, Antikainen H, Bonder EM, et al. The Amino Acid Metabolite Homocysteine Activates Mtorc1 to Inhibit Autophagy and Form Abnormal Proteins in Human Neurons and Mice. FASEB Journal : official publication of the Federation of American Societies for Experimental Biology. 2017;31(2):598-609. PMID: 28148781.

23.    Koh WJ, Greer BE, Abu-Rustum NR, et al. Vulvar Cancer, Version 1.2017 Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network: JNCCN. 2017;15(1):92-120.

24.    Koller SE, Bauer KW, Egleston BL, et al. Comparative Effectiveness and Risks of Bowel Preparation before Elective Colorectal Surgery. Annals of Surgery. 2017.

25.    Kudinov AE, Karanicolas J, Golemis EA, Boumber Y. Musashi Rna-Binding Proteins as Cancer Drivers and Novel Therapeutic Targets. Clinical Cancer Research : an official journal of the American Association for Cancer Research. 2017. PMID: 28143872.

26.    Lilge L, Terry MB, Walter J, et al. Non-Invasive Optical Spectroscopic Monitoring of Breast Development During Puberty. Breast Cancer Research : BCR. 2017;19(1):12. PMID: 28166807. PMC5294901.

27.    Metcalfe MJ, Smaldone MC, Lin DW, Aparicio AM, Chapin BF. Role of Radical Prostatectomy in Metastatic Prostate Cancer: A Review. Urologic Oncology. 2017. PMID: 28190749.

28.    Miller KD, Rall GF. What Kaplan-Meier Survival Curves Don’t Tell Us About Cns Disease. Journal of Neuroimmunology. 2017. PMID: 28187911.

29.    Miller SM, Tagai EK, Wen KY, et al. Predictors of Adherence to Follow-up Recommendations after an Abnormal Pap Smear among Underserved Inner-City Women. Patient Education and Counseling. 2017. PMID: 28190541.

30.    Mullinax JE, Kroon HM, Thompson JF, et al. Isolated Limb Infusion as a Limb Salvage Strategy for Locally Advanced Extremity Sarcoma. Journal of the American College of Surgeons. 2017. PMID: 28214556.

31.    Ng C, Zhang Z, Lee SI, et al. Ct Perfusion as an Early Biomarker of Treatment Efficacy in Advanced Ovarian Cancer: An Acrin and Gog Study. Clinical Cancer Research : an official journal of the American Association for Cancer Research. 2017. PMID: 28174234.

32.    Orcutt KD, Adams GP, Wu AM, et al. Molecular Simulation of Receptor Occupancy and Tumor Penetration of an Antibody and Smaller Scaffolds: Application to Molecular Imaging. Molecular Imaging and Biology : MIB : the official publication of the Academy of Molecular Imaging. 2017. PMID: 28213834.

33.    Pang JH, Patel SA, King SA, Curcillo PG, 2nd, Weiss ES, Buchanan DR. Reduced-Port Approach to Laparoscopic Flap Harvest (Ralfh): An Anterior Sheath Sparing Rectus Abdominis Flap. Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS. 2017. PMID: 28238721.

34.    Prinsep MR, Appleton TG, Hanson GR, et al. Tolyporphin Macrocycles from the Cyanobacterium Tolypothrix Nodosa Selectively Bind Copper and Silver and Reverse Multidrug Resistance. Inorganic Chemistry. 2017. PMID: 28240882.

35.    Prouet P, Giri S, Wiedower E, et al. Addition of Rituximab to Chemotherapy Reduced the Rate of Surgery for Gastric-Dlbcl without Increasing Early Mortality. Anticancer Research. 2017;37(2):813-817. PMID: 28179335.

36.    Sato T, Issa JJ, Kropf P. DNA Hypomethylating Drugs in Cancer Therapy. Cold Spring Harbor Perspectives in Medicine. 2017. PMID: 28159832.

37.    Schuetze KB, Stratton MS, Blakeslee WW, et al. Overlapping and Divergent Actions of Structurally Distinct Hdac Inhibitors in Cardiac Fibroblasts. The Journal of Pharmacology and Experimental Therapeutics. 2017. PMID: 28174211.

38.    Semenova G, Chernoff J. Targeting Pak1. Biochemical Society Transactions. 2017;45(1):79-88. PMID: 28202661.

39.    Shaikh T, Li T, Handorf EA, et al. Long-Term Patient-Reported Outcomes from a Phase 3 Randomized Prospective Trial of Conventional Versus Hypofractionated Radiation Therapy for Localized Prostate Cancer. International Journal of Radiation Oncology, biology, physics. 2017;97(4):722-731. PMID: 28244407.

40.    Skates SJ, Greene MH, Buys SS, et al. Early Detection of Ovarian Cancer Using the Risk of Ovarian Cancer Algorithm with Frequent Ca125 Testing in Women at Increased Familial Risk – Combined Results from Two Screening Trials. Clinical Cancer Research : an official journal of the American Association for Cancer Research. 2017. PMID: 28143870.

41.    Teye EK, Sido A, Xin P, et al. Pign Gene Expression Aberration Is Associated with Genomic Instability and Leukemic Progression in Acute Myeloid Leukemia with Myelodysplastic Features. Oncotarget. 2017. PMID: 28187452.

42.    Waingankar N, Mallin K, Smaldone M, et al. Assessing the Relative Influence of Hospital and Surgeon Volume on Short-Term Mortality Following Radical Cystectomy. BJU International. 2017. PMID: 28192632.

43.    Weldon CB, Madenci AL, Boikos SA, et al. Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report from the National Institutes of Health Pediatric and Wildtype Gist Clinic. Journal of Clinical Oncology. 2017;35(5):523-528.

44.    Zaorsky NG, Williams GR, Barta SK, et al. Splenic Irradiation for Splenomegaly: A Systematic Review. Cancer Treatment Reviews. 2017;53:47-52. PMID: 28063304.

EndNote’s NIH Output Style Helps You with the new NIH Bibliography Format

We have been getting phone calls of late regarding changes to the NIH bibliography format. As of March 2016, “anyone submitting an application, proposal or report to the NIH must include the PMC reference number (PMCID) when citing applicable papers that they author or that arise from their NIH-funded research.” The other requirement is that all authors of a given article be listed in the bibliographic citation. If you have EndNote, you can kill both birds with one stone.

Back in 2014, the NIH created an EndNote output style called NIH (Grant Format). In this style, all of the authors are included and the PMID and PMCID are added automatically. To see if the NIH format is included in your version of EndNote:

  1. In EndNote for Windows, click on the Bibliographic Output Style drop-down arrow located in the EndNote toolbar.
  2. Check the list provided and click NIH, if it appears.

The drop-down list of output styles is an alphabetical list of your most heavily-used styles. If you do not see NIH on that list, proceed as follows:

  1. In EndNote for Windows, click on the Bibliographic Output Style drop-down arrow located in the EndNote toolbar.
  2. Click Select Another Style.
  3. Output styles are arranged alphabetically by name. Scroll down to and click NIH if it appears on the list.
  4. Click Choose.

If you do not see NIH in the Choose a Style box, it may be installed just not visible:

  1. In EndNote for Windows, click Edit, then click Output Styles, and then click Open Style Manager.
  2. In the EndNote Styles box, scroll down to and select the NIH checkbox.
  3. Close the EndNote Styles box.

If you do not see NIH in the EndNote Styles box, it may not be installed and proceed as follows:

  1. Google EndNote downloads.
  2. Click Downloads | EndNote | Clarivate Analytics
  3. Scroll down to and click Add output styles.
  4. In the text box located directly under the Publisher drop-down list, type NIH.
  5. Click NIH (Grant Format).
  6. Click Download this Style.
  7. In the Opening NIH.ens box, make sure that Open with is selected and EndNote X8 (or X7) appears as the default.
    If you do not see EndNote, click the down arrow then click Other, click EndNote, and then click OK.
  8. Click OK.
  9. In EndNote, click File and then click Save As.
  10. In the Style Name text box, delete Copy if it appears.
  11. Click Save.

If your article has been submitted to PMC by the publisher and does not have a PMCID yet use “PMC Journal – In Process”. If either the publisher, the author, or the author’s designee has submitted the manuscript using the NIHMS, provide a valid NIH Manuscript Submission System reference number (NIHMSID) until the PMCID becomes available. Whatever method of deposit you use, be sure to add the PMCID when it becomes available. If your article was accepted for publication before the NIH Public Access Policy went into effect, then no special notation is required.

For more information about when to include the PMCID see, NIH Public Access Policy Include PMCID in Citation.

Staff Publications – January 2017

1.    Afifi M, Deiab N, El-Farrash A, et al. Su-F-T-281: Monte Carlo Investigation of Sources of Dosimetric Discrepancies with 2d Arrays. Medical physics. 2016;43(6):3527. PMID: 28047911.
2.    Al Ashkar E, Eldib A, Eraba K, Imam M, Ma C. Su-F-T-79: Monte Carlo Investigation of Optimizing Parameters for Modulated Electron Arc Therapy. Medical physics. 2016;43(6):3479. PMID: 28048738.
3.    Andersen CL, Sikora MJ, Boisen MM, et al. Active Estrogen Receptor-Alpha Signaling in Ovarian Cancer Models and Clinical Specimens. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017. PMID: 28073843.
4.    Ariazi EA, Taylor JC, Black MA, et al. A New Role for Eralpha: Silencing Via DNA Methylation of Basal, Stem Cell, and Emt Genes. Molecular cancer research : MCR. 2016. PMID: 28108626.
5.    Bodson J, Ding Q, Warner EL, Hawkins AJ, Henry KA, Kepka D. Sub-Regional Assessment of Hpv Vaccination among Female Adolescents in the Intermountain West and Implications for Intervention Opportunities. Maternal and child health journal. 2017. PMID: 28092058.
6.    Burns KE, Hensley H, Robinson MK, Thevenin D. Therapeutic Efficacy of a Family of Phlip-Mmaf Conjugates in Cancer Cells and Mouse Models. Molecular pharmaceutics. 2017. PMID: 28048942.
7.    Buys SS, Sandbach JF, Gammon A, et al. A Study of over 35,000 Women with Breast Cancer Tested with a 25-Gene Panel of Hereditary Cancer Genes. Cancer. 2017. PMID: 28085182.
8.    Carrer A, Parris JL, Trefely S, et al. Impact of High Fat Diet on Tissue Acyl-Coa and Histone Acetylation Levels. The Journal of biological chemistry. 2017. PMID: 28077572.
9.    Chen L, Cvetkovic D, Chen X, Wang B, Gupta R, Ma C. We-Ab-Bra-02: Study of the Therapeutic Effects of Pulsed Focused Ultrasound Combined with Encapsulated Chemotherapeutic Agents for Prostate Cancer in Vivo. Medical physics. 2016;43(6):3791. PMID: 28048451.
10.    Chen L, Cvetkovic D, Chen X, Wang B, Gupta R, Ma C. Su-F-J-225: Histology Study of Mr Guided Pulsed Focused Ultrasound on Treatment of Prostate Cancer in Vivo. Medical physics. 2016;43(6):3460-3461. PMID: 28046739.
11.    Chibani O, Fan J, Tahanout F, Eldib A, Ma C. Su-F-T-375: Optimization of a New Co-60 Machine for Intensity Modulated Radiation Therapy: A Monte Carlo Characterization Study. Medical physics. 2016;43(6):3549. PMID: 28047825.
12.    Chibani O, Tahanout F, Ma C. Tu-Ab-Brc-04: Commissioning of a New Mlc Model for the Gepts Monte Carlo System: A Model Based on the Leaf and Interleaf Effective Density. Medical physics. 2016;43(6):3730. PMID: 28048146.
13.    Cornell RF, D’Souza A, Kassim AA, et al. Maintenance Versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma. Biology of Blood and Marrow Transplantation. 2017;23(2):269-277.
14.    Costa LJ, Maddocks K, Epperla N, et al. Diffuse Large B-Cell Lymphoma with Primary Treatment Failure: Ultra-High Risk Features and Benchmarking for Experimental Therapies. American Journal of Hematology. 2017;92(2):161-170.
15.    Cvetkovic D, Wang B, Gupta R, Ma C. Su-F-T-674: In Vitro Study of 5-Aminolevulinic Acid-Mediated Photo Dynamic Therapy in Human Cancer Cell Lines. Medical physics. 2016;43(6):3619. PMID: 28048178.
16.    Deer TR, Pope JE, Hayek SM, et al. The Polyanalgesic Consensus Conference (Pacc): Recommendations for Intrathecal Drug Delivery: Guidance for Improving Safety and Mitigating Risks. Neuromodulation : journal of the International Neuromodulation Society. 2017. PMID: 28042914.
17.    Eldib A, Chibani O, Chen L, Li J, Price R, Ma C. Su-F-T-524: Investigation of the Dosimertric Benefits of Interchangeable Source Size of a Novel Rotating Gamma System. Medical physics. 2016;43(6):3583-3584. PMID: 28047166.
18.    Eldib A, Chibani O, Mora G, et al. Su-F-T-649: Dosimetric Evaluation of Non-Coplanar Arc Therapy Using a Novel Rotating Gamma Ray System. Medical physics. 2016;43(6):3613. PMID: 28046237.
19.    Fan J, Lin T, Jin L, et al. Mo-Fg-Campus-Jep3-05: Evaluation of 4d Ct-on-Rails Target Localization Methods for Free Breathing Liver Stereotactic Body Radiotherapy (Sbrt). Medical physics. 2016;43(6):3727. PMID: 28047328.
20.    Finelli A, Ismaila N, Bro B, et al. Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017:Jco2016699645. PMID: 28095147.
21.    Franco-Barraza J, Francescone R, Luong T, et al. Matrix-Regulated Integrin Alphavbeta5 Maintains Alpha5beta1-Dependent Desmoplastic Traits Prognostic of Neoplastic Recurrence. eLife. 2017;6. PMID: 28139197.
22.    George E, Kim H, Krepler C, et al. A Patient-Derived-Xenograft Platform to Study Brca-Deficient Ovarian Cancers. JCI insight. 2017;2(1):e89760. PMID: 28097235. PMC5214535.
23.    Gross S, Kotova EY, Maluchenko NV, Pascal JM, Studitsky VM. Evaluating Parp1 Domains as Gossypol Targets. Moscow University Biological Sciences Bulletin. 2016;71(4):235-239.
24.    Gupta R, Cvetkovic D, Wang B, Chen L, Ma C. We-Ab-Bra-01: Biodistribution of Paclitaxel-Loaded Nanodroplets for Prostate Cancer Management Using Ultrasound-Mediated Drug Delivery under Mrguidance. Medical physics. 2016;43(6):3791. PMID: 28046379.
25.    Gupta R, Eldib A, Li J, Ma C. Su-F-T-610: Comparison of Output Factors for Small Radiation Fields Used in Sbrt Treatment. Medical physics. 2016;43(6):3604. PMID: 28047767.
26.    Hayakawa K, Formica AM, Brill-Dashoff J, et al. Early Generated B1 B Cells with Restricted Bcrs Become Chronic Lymphocytic Leukemia with Continued C-Myc and Low Bmf Expression. Journal of Experimental Medicine. 2016;213(13):3007-3023.
27.    Huang JF, Zhang FZ, Zou QZ, et al. Induction Chemotherapy Followed by Concurrent Chemoradiation and Nimotuzumab for Locoregionally Advanced Nasopharyngeal Carcinoma: Preliminary Results from a Phase Ii Clinical Trial. Oncotarget. 2017;8(2):2457-2465.
28.    Infante JR, Patnaik A, Verschraegen CF, et al. Two Phase 1 Dose-Escalation Studies Exploring Multiple Regimens of Litronesib (Ly2523355), an Eg5 Inhibitor, in Patients with Advanced Cancer. Cancer chemotherapy and pharmacology. 2017. PMID: 28097385.
29.    Jin L, Fan J, Eldib A, Price R, Ma C. Su-F-T-81: Treating Nose Skin Using Energy and Intensity Modulated Electron Beams with Monte Carlo Based Dose Calculation. Medical physics. 2016;43(6):3480. PMID: 28047422.
30.    John EM, Terry MB, Keegan TH, et al. The Legacy Girls Study: Growth and Development in the Context of Breast Cancer Family History. Epidemiology (Cambridge, Mass). 2016;27(3):438-448. PMID: 26829160.
31.    Kang J, Zhang S, Philbrook S, Paul S, Wang B. Su-F-T-416: Dosimetric Comparison of Coplanar and Non-Coplanar Imrt Plans for Peripheral Lung Lesion. Medical physics. 2016;43(6):3558-3559. PMID: 28047745.
32.    Kelly AD, Kroeger H, Yamazaki J, et al. A Cpg Island Methylator Phenotype in Acute Myeloid Leukemia Independent of Idh Mutations and Associated with a Favorable Outcome. Leukemia. 2017. PMID: 28074068.
33.    Kutikov A, Uzzo RG, Smaldone MC, Haifler M, Bratslavsky G, Leibovich BC. Reply to Patrick O. Richard, Micheal as Jewett and Antonio Finelli’s Letter to the Editor Re: Alexander Kutikov, Marc C. Smaldone, Robert G. Uzzo, Miki Haifler, Gennady Bratslavsky, Bradley C. Leibovich. Renal Mass Biopsy: Always, Sometimes, or Never? Eur Urol. In Press. Http://Dx.Doi.Org/10.1016/J.Eururo.2016.04.001. European Urology. 2017;71(2):E47-E48.
34. HO, Wang LQ, Kuo YM, et al. Lack of Global Epigenetic Methylation Defects in Cbs Deficient Mice. Journal of Inherited Metabolic Disease. 2017;40(1):113-120.
35.    Lin T, Ma C. Su-F-J-117: Impact of Motion Artifacts on Image Quality and Accuracy of Tumor Motion Reconstruction in 4d Ct-on-Rails and Mv-Cbct Scans: A Phantom Study. Medical physics. 2016;43(6):3433-3434. PMID: 28048240.
36.    Lin T, Wang L, Galloway T, Ma C. Su-F-J-13: Choosing an Imrt Technique in the Treatment of Head and Neck Cancer with Daily Localization Uncertainties. Medical physics. 2016;43(6):3408. PMID: 28047351.
37.    Litwin S, Basickes S, Ross EA. Two-Sample Binary Phase 2 Trials with Low Type I Error and Low Sample Size. Statistics in medicine. 2017. PMID: 28118686.
38.    Liu J, Eldib A, Lin M, Li J, Mora G, Ma C. Su-G-Brc-08: Evaluation of Dose Mass Histogram as a More Representative Dose Description Method Than Dose Volume Histogram in Lung Cancer Patients. Medical physics. 2016;43(6):3628. PMID: 28047740.
39.    Lydiatt WM, Patel SG, O’Sullivan B, et al. Head and Neck Cancers-Major Changes in the American Joint Committee on Cancer Eighth Edition Cancer Staging Manual. CA: a cancer journal for clinicians. 2017. PMID: 28128848.
40.    Ma C, Chibani O, Eldib A, Li J, Chen L. Su-F-T-529: Dosimetric Investigation of a Rotating Gamma Ray System for Imagedguided Modulated Arc Radiotherapy. Medical physics. 2016;43(6):3584-3585. PMID: 28048393.
41.    Ma C, Wang B, Cvetkovic D, Chen L. Su-F-J-216: Mr-Guided Non-Thermal Pulsed Focused Ultrasound for Cancer Therapy. Medical physics. 2016;43(6):3458. PMID: 28048114.
42.    Ma GX, Fang CY, Seals B, et al. A Community-Based Randomized Trial of Hepatitis B Screening among High-Risk Vietnamese Americans. American journal of public health. 2017:e1-e8. PMID: 28103075.
43.    Manne SL, Virtue SM, Ozga M, et al. A Comparison of Two Psychological Interventions for Newly-Diagnosed Gynecological Cancer Patients. Gynecologic Oncology. 2017;144(2):354-362.
44.    Mesa R, Jamieson C, Bhatia R, et al. Myeloproliferative Neoplasms, Version 2.2017. Journal of the National Comprehensive Cancer Network. 2016;14(12):1572-1611.
45.    Minervini A, Campi R, Sessa F, et al. Positive Surgical Margins and Local Recurrence after Simple Enucleation and Standard Partial Nephrectomy for Malignant Renal Tumors: Systematic Review of the Literature and Meta-Analysis of Prevalence. Minerva urologica e nefrologica = The Italian journal of urology and nephrology. 2017. PMID: 28124871.
46.    Mirhadi AJ, Zhang Q, Hanks GE, et al. Effect of Long-Term Hormonal Therapy (Vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on Nrg Oncology Rtog 9202. International journal of radiation oncology, biology, physics. 2017;97(3):511-515. PMID: 28126300.
47.    Mookerjee-Basu J, Kappes DJ. Inkt Cells Do a Fat Lot of Good. Nature Immunology. 2017;18(1):10-12.
48.    O’Malley D, Dewan AA, Ohman-Strickland P, Gundersen DA, Miller SM, Hudson SV. Determinants of Patient Activation in a Community Sample of Breast and Prostate Cancer Survivors. Psycho-oncology. 2017. PMID: 28133892.
49.    Plimack ER, Bellmunt J, Gupta S, et al. Safety and Activity of Pembrolizumab in Patients with Locally Advanced or Metastatic Urothelial Cancer (Keynote-012): A Non-Randomised, Open-Label, Phase 1b Study. The Lancet Oncology. 2017. PMID: 28081914.
50.    Price R, Veltchev I, Lin T, Gleason R, Ma C. Su-F-T-345: Quasi-Dead Beams: Clinical Relevance and Implications for Automatic Planning. Medical physics. 2016;43(6):3542. PMID: 28048497.
51.    Ristau BT, Smaldone MC. Radical Prostatectomy in Metastatic Prostate Cancer: Is There Enough Evidence? Vertical Bar Opinion: No. International Braz J Urol. 2016;42(5):880-882.
52.    Roy I, Boyle KA, Vonderhaar EP, et al. Cancer Cell Chemokines Direct Chemotaxis of Activated Stellate Cells in Pancreatic Ductal Adenocarcinoma. Laboratory investigation; a journal of technical methods and pathology. 2017. PMID: 28092365.
53.    Seabloom DE, Galbraith AR, Haynes AM, et al. Fixed-Dose Combinations of Pioglitazone and Metformin for Lung Cancer Prevention. Cancer prevention research (Philadelphia, Pa). 2017. PMID: 28052934.
54.    Semenova G, Stepanova D, Deyev SM, Chernoff J. Medium Throughput Biochemical Compound Screening Identifies Novel Agents for Pharmacotherapy of Neurofibromatosis Type I. Biochimie. 2017. PMID: 28065690.
55.    Shapiro GI, Vaishampayan UN, LoRusso P, et al. First-in-Human Trial of an Anti-5t4 Antibody-Monomethylauristatin Conjugate, Pf-06263507, in Patients with Advanced Solid Tumors. Investigational new drugs. 2017. PMID: 28070718.
56.    Sharma P, Retz M, Siefker-Radtke A, et al. Nivolumab in Metastatic Urothelial Carcinoma after Platinum Therapy (Checkmate 275): A Multicentre, Single-Arm, Phase 2 Trial. The Lancet Oncology. 2017. PMID: 28131785.
57.    Skalka AM, Andrake MD, Katz RA. Successes and Challenges with Retroviral Enzymes. Postepy biochemii. 2016;62(3):280-285. PMID: 28132482.
58.    Soni RS, Ebersole B, Jamal N. Treatment of Chronic Cough. Otolaryngology–head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2017;156(1):103-108. PMID: 28045638.
59.    Stroup AM, Herget KA, Hanson HA, et al. Baby Boomers and Birth Certificates: Early-Life Socioeconomic Status and Cancer Risk in Adulthood. Cancer Epidemiology Biomarkers and Prevention. 2017;26(1):75-84.
60.    Tan Y, Sementino E, Xu J, et al. The Homeoprotein Dlx5 Drives Murine T-Cell Lymphomagenesis by Directly Transactivating Notch and Upregulating Akt Signaling. Oncotarget. 2017. PMID: 28122332.
61.    Tonisen F, Perrin L, Bayarmagnai B, van den Dries K, Cambi A, Gligorijevic B. Ep4 Receptor Promotes Invadopodia and Invasion in Human Breast Cancer. European journal of cell biology. 2017. PMID: 28094049.
62.    Valieva ME, Gerasimova NS, Kudryashova KS, et al. Stabilization of Nucleosomes by Histone Tails and by Fact Revealed by Spfret Microscopy. Cancers. 2017;9(1). PMID: 28067802.
63.    Veltchev I, Price R, Anderson P, Ma C. Su-F-T-07: Dosimetric Impact of the Dwell Position Inaccuracy in Hdr Ring and Tandem Treatments with Varisourceix Afterloader. Medical physics. 2016;43(6):3462-3463. PMID: 28048740.
64.    Veltchev I, Price R, Horwitz E, Ma C. Su-F-T-34: Transition Form Ct-Based to Ultrasound-Based Hdr Treatment Planning for Prostate Cancer. Medical physics. 2016;43(6):3469. PMID: 28047569.
65.    Waingankar N, Bratslavsky G, Jimenez C, Russo P, Kutikov A. Pheochromocytoma in Urologic Practice. European urology focus. 2016;1(3):231-240. PMID: 28078330. PMC5222610.
66.    Wang B, He W, Cvetkovic D, Chen L, Fan J, Ma C. Su-G-Iep4-11: Monitoring Tumor Growth in Subcutaneous Murine Tumor Model in Vivo: A Comparison between Mri and Small Animal Ct. Medical physics. 2016;43(6):3680. PMID: 28047612.
67.    Wang B, He W, Cvetkovic D, Chen L, Ma C. Su-F-J-215: Non-Thermal Pulsed High Intensity Focused Ultrasound Therapy Combined with 5-Aminolevulinic Acid: An in Vivo Pilot Study. Medical physics. 2016;43(6):3458. PMID: 28048774.
68.    Wang HH, Zaorsky NG, Meng MB, et al. Stereotactic Radiation Therapy for Oligometastases or Oligorecurrence within Mediastinal Lymph Nodes. Oncotarget. 2016;7(14):18135-18145. PMID: 26919113. PMC4951277.
69.    Weitzner BD, Jeliazkov JR, Lyskov S, et al. Modeling and Docking of Antibody Structures with Rosetta. Nature protocols. 2017;12(2):401-416. PMID: 28125104.
70.    Williams SB, Huo J, Chamie K, et al. Discerning the Survival Advantage among Patients with Prostate Cancer Who Undergo Radical Prostatectomy or Radiotherapy: The Limitations of Cancer Registry Data. Cancer. 2017. PMID: 28099688.
71.    Zaorsky NG, Williams GR, Barta SK, et al. Splenic Irradiation for Splenomegaly: A Systematic Review. Cancer treatment reviews. 2016;53:47-52. PMID: 28063304.
72.    Zhang Q, Sun QY, Xiao GP, et al. We-Fg-Bra-12: Research Work of the Radio-Dynamic Treatment Mechanism. Medical physics. 2016;43(6):3826. PMID: 28047568.
73.    Zhang Y, O’Leary MN, Peri S, et al. Ribosomal Proteins Rpl22 and Rpl22l1 Control Morphogenesis by Regulating Pre-Mrna Splicing. Cell reports. 2017;18(2):545-556. PMID: 28076796. PMC5234864.
74.    Zuniga S, Ebersole B, Jamal N. Inpatient Injection Laryngoplasty for Vocal Fold Immobility: When Is It Really Necessary? American journal of otolaryngology. 2017. PMID: 28131551.